Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 2013

Dennison Jennifer B, Molina Jennifer R, Mitra Shreya, González-Angulo Ana M, Balko Justin M, Kuba María G, Sanders Melinda E, Pinto Joseph A, Gómez Henry L, Arteaga Carlos L, Brown Robert E, Mills Gordon B

Abstract excerpt

PURPOSE: Although breast cancers are known to be molecularly heterogeneous, their metabolic phenotype is less well-understood and may predict response to chemotherapy. This study aimed to evaluate metabolic genes as individual predictive biomarkers in breast cancer. EXPERIMENTAL DESIGN: mRNA micr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Glycolysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoenzymes

Share to L-Lactate Dehydrogenase

Share to Neoadjuvant Therapy

Share to Oxygen Consumption

Share to Transcriptome

Share to Triple Negative Breast Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23697991
DOI: 10.1158/1078-0432.CCR-13-0623
PMCID: PMC3727144

Genes

LDHB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23697991-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.PMID 23697991Read ↗

An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast CancerSemantic proximity Read ↗

Characterization of Lactate Metabolism Score in Breast and Thyroid Cancers to Assist Immunotherapy via Large-Scale Transcriptomic Data AnalysisSemantic proximity Read ↗

A lactate‐responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple‐negative breast cancerSemantic proximity Read ↗

A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancerSemantic proximity Read ↗

Characterization of metabolic phenotypes in breast cancer through the integration of genome-scale metabolic models and machine learningSemantic proximity Read ↗

Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.Semantic proximity Read ↗

Correlation between metabolic characteristics and breast cancer subtypes and prognosisSemantic proximity Read ↗

Identification of Lactate-Related Subgroups and Prognostic Model in Triple-Negative Breast CancerSemantic proximity Read ↗

miR-526b dysregulates glucose metabolism via the COX2/EP4 pathwaySemantic proximity Read ↗

Integrated Metabolic and Gene Expression Profiling Reveals New Therapeutic Modalities for Rapidly Proliferating Breast CancersSemantic proximity Read ↗

Proteogenomic Metabolism Dependent Signature Identifies Worse Outcome in Breast And Other CancersSemantic proximity Read ↗

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasivenessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.